𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic factors for advanced seminoma—a solid basis for clinical trials

✍ Scribed by H.-J. Schmoll

Book ID
117663769
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
473 KB
Volume
33
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic factors for survival in patie
Prognostic factors for survival in patients treated in phase I clinical trials
✍ Linda Janisch; Rosemarie Mick; Richard L. Schilsky; Nicholas J. Vogelzang; Sheil 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 720 KB

Background. Patients with advanced or metastatic cancer treated in Phase I clinical trials are considered to have a poor prognosis. Survival from first treatment in a Phase I trial was determined for 349 patients. Univariate and multivariate survival analyses were performed to determine whether pote

A rationale for expanding the endpoints
A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma
✍ Mace L. Rothenberg; James L. Abbruzzese; Malcolm Moore; Russell K. Portenoy; Joh 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 689 KB

## BACKGROUND. Using classical endpoints, such as response rate and survival, as the sole measures of benefit, little progress has been made in the treatment of advanced pancreatic carcinoma in the past 30 years. We challenge the assumption that response rate and survival are the only appropriate